HEADER TRANSFERASE/INHIBITOR 07-OCT-14 4RIO TITLE CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A TITLE 2 PYRROLOPYRIDAZINE CARBOXAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 810-1100); COMPND 5 SYNONYM: JANUS KINASE 3, JAK-3, LEUKOCYTE JANUS KINASE, L-JAK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS TRANSFER VECTOR KEYWDS TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 1 24-DEC-14 4RIO 0 JRNL AUTH J.J.DUAN,Z.LU,B.JIANG,B.V.YANG,L.M.DOWEYKO,D.S.NIRSCHL, JRNL AUTH 2 L.E.HAQUE,S.LIN,G.BROWN,J.HYNES,J.S.TOKARSKI,J.S.SACK, JRNL AUTH 3 J.KHAN,J.S.LIPPY,R.F.ZHANG,S.PITT,G.SHEN,W.J.PITTS, JRNL AUTH 4 P.H.CARTER,J.C.BARRISH,S.G.NADLER,L.M.SALTER-CID,M.MCKINNON, JRNL AUTH 5 A.FURA,G.L.SCHIEVEN,S.T.WROBLESKI JRNL TITL DISCOVERY OF PYRROLO[1,2-B]PYRIDAZINE-3-CARBOXAMIDES AS JRNL TITL 2 JANUS KINASE (JAK) INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 5721 2014 JRNL REFN ISSN 0960-894X JRNL PMID 25453808 JRNL DOI 10.1016/J.BMCL.2014.10.061 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 9202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 464 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.01 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.65 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2533 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2205 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2398 REMARK 3 BIN R VALUE (WORKING SET) : 0.2152 REMARK 3 BIN FREE R VALUE : 0.3143 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.33 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2206 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 64.08 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -17.33030 REMARK 3 B22 (A**2) : 21.00980 REMARK 3 B33 (A**2) : -3.67960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.338 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.905 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.892 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.860 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2281 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3100 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 769 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 349 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2281 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 282 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2625 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.97 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.71 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RIO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-14. REMARK 100 THE RCSB ID CODE IS RCSB087393. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL2000 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL2000 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9255 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.17900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.61100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG-3350, 200MM MAGNESIUM CHLORIDE REMARK 280 100MM BIS-TRIS PH 5.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.77000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.99000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.72000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.99000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.77000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.72000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 808 REMARK 465 PRO A 809 REMARK 465 ALA A 810 REMARK 465 SER A 811 REMARK 465 GLN A 812 REMARK 465 ASP A 813 REMARK 465 PRO A 814 REMARK 465 SER A 1100 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 823 CG CD CE NZ REMARK 470 LYS A 830 CG CD CE NZ REMARK 470 PHE A 833 CG CD1 CD2 CE1 CE2 CZ REMARK 470 HIS A 859 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 866 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 870 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 895 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 984 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 985 CG CD OE1 OE2 REMARK 470 LYS A1026 CG CD CE NZ REMARK 470 ARG A1036 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1049 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1052 CG CD OE1 OE2 REMARK 470 GLU A1055 CG CD OE1 OE2 REMARK 470 GLN A1083 CG CD OE1 NE2 REMARK 470 MET A1097 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 833 -7.22 80.88 REMARK 500 ASP A 842 78.66 -115.18 REMARK 500 PRO A 862 95.68 -20.70 REMARK 500 ASP A 863 -43.76 177.62 REMARK 500 LEU A 898 140.15 73.63 REMARK 500 ASP A 949 34.36 -143.34 REMARK 500 ASP A 967 82.00 60.58 REMARK 500 GLU A 985 -97.13 -21.14 REMARK 500 PRO A 986 -159.56 -95.54 REMARK 500 TYR A1023 35.02 39.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3QX A 4000 DBREF 4RIO A 810 1100 UNP P52333 JAK3_HUMAN 810 1100 SEQADV 4RIO GLY A 808 UNP P52333 EXPRESSION TAG SEQADV 4RIO PRO A 809 UNP P52333 EXPRESSION TAG SEQADV 4RIO SER A 811 UNP P52333 CYS 811 ENGINEERED MUTATION SEQADV 4RIO SER A 1040 UNP P52333 CYS 1040 ENGINEERED MUTATION SEQADV 4RIO SER A 1048 UNP P52333 CYS 1048 ENGINEERED MUTATION SEQRES 1 A 293 GLY PRO ALA SER GLN ASP PRO THR ILE PHE GLU GLU ARG SEQRES 2 A 293 HIS LEU LYS TYR ILE SER GLN LEU GLY LYS GLY ASN PHE SEQRES 3 A 293 GLY SER VAL GLU LEU CYS ARG TYR ASP PRO LEU GLY ASP SEQRES 4 A 293 ASN THR GLY ALA LEU VAL ALA VAL LYS GLN LEU GLN HIS SEQRES 5 A 293 SER GLY PRO ASP GLN GLN ARG ASP PHE GLN ARG GLU ILE SEQRES 6 A 293 GLN ILE LEU LYS ALA LEU HIS SER ASP PHE ILE VAL LYS SEQRES 7 A 293 TYR ARG GLY VAL SER TYR GLY PRO GLY ARG GLN SER LEU SEQRES 8 A 293 ARG LEU VAL MET GLU TYR LEU PRO SER GLY CYS LEU ARG SEQRES 9 A 293 ASP PHE LEU GLN ARG HIS ARG ALA ARG LEU ASP ALA SER SEQRES 10 A 293 ARG LEU LEU LEU TYR SER SER GLN ILE CYS LYS GLY MET SEQRES 11 A 293 GLU TYR LEU GLY SER ARG ARG CYS VAL HIS ARG ASP LEU SEQRES 12 A 293 ALA ALA ARG ASN ILE LEU VAL GLU SER GLU ALA HIS VAL SEQRES 13 A 293 LYS ILE ALA ASP PHE GLY LEU ALA LYS LEU LEU PRO LEU SEQRES 14 A 293 ASP LYS ASP TYR TYR VAL VAL ARG GLU PRO GLY GLN SER SEQRES 15 A 293 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU SER ASP ASN SEQRES 16 A 293 ILE PHE SER ARG GLN SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 293 VAL LEU TYR GLU LEU PHE THR TYR CYS ASP LYS SER CYS SEQRES 18 A 293 SER PRO SER ALA GLU PHE LEU ARG MET MET GLY SER GLU SEQRES 19 A 293 ARG ASP VAL PRO ALA LEU SER ARG LEU LEU GLU LEU LEU SEQRES 20 A 293 GLU GLU GLY GLN ARG LEU PRO ALA PRO PRO ALA CYS PRO SEQRES 21 A 293 ALA GLU VAL HIS GLU LEU MET LYS LEU CYS TRP ALA PRO SEQRES 22 A 293 SER PRO GLN ASP ARG PRO SER PHE SER ALA LEU GLY PRO SEQRES 23 A 293 GLN LEU ASP MET LEU TRP SER HET 3QX A4000 20 HETNAM 3QX 4-{[(1R,2S)-2-FLUORO-2- HETNAM 2 3QX METHYLCYCLOPENTYL]AMINO}PYRROLO[1,2-B]PYRIDAZINE-3- HETNAM 3 3QX CARBOXAMIDE FORMUL 2 3QX C14 H17 F N4 O FORMUL 3 HOH *22(H2 O) HELIX 1 1 ASP A 863 ALA A 877 1 15 HELIX 2 2 CYS A 909 HIS A 917 1 9 HELIX 3 3 ARG A 918 LEU A 921 5 4 HELIX 4 4 ASP A 922 ARG A 943 1 22 HELIX 5 5 ALA A 951 ARG A 953 5 3 HELIX 6 6 PRO A 990 TYR A 994 5 5 HELIX 7 7 ALA A 995 ASN A 1002 1 8 HELIX 8 8 ARG A 1006 THR A 1022 1 17 HELIX 9 9 SER A 1029 GLY A 1039 1 11 HELIX 10 10 PRO A 1045 GLU A 1056 1 12 HELIX 11 11 PRO A 1067 TRP A 1078 1 12 HELIX 12 12 SER A 1081 ARG A 1085 5 5 HELIX 13 13 SER A 1087 TRP A 1099 1 13 SHEET 1 A 6 ILE A 816 GLU A 818 0 SHEET 2 A 6 TYR A 886 TYR A 891 1 O TYR A 891 N PHE A 817 SHEET 3 A 6 LEU A 900 GLU A 903 -1 O VAL A 901 N ARG A 887 SHEET 4 A 6 ALA A 850 LEU A 857 -1 N ALA A 853 O MET A 902 SHEET 5 A 6 GLY A 834 TYR A 841 -1 N CYS A 839 O VAL A 852 SHEET 6 A 6 LEU A 822 GLY A 829 -1 N ILE A 825 O LEU A 838 SHEET 1 B 2 CYS A 945 VAL A 946 0 SHEET 2 B 2 LYS A 972 LEU A 973 -1 O LYS A 972 N VAL A 946 SHEET 1 C 2 ILE A 955 SER A 959 0 SHEET 2 C 2 HIS A 962 ILE A 965 -1 O LYS A 964 N LEU A 956 SHEET 1 D 2 TYR A 980 VAL A 982 0 SHEET 2 D 2 ILE A1003 SER A1005 -1 O PHE A1004 N TYR A 981 CISPEP 1 GLY A 894 ARG A 895 0 0.77 CISPEP 2 GLN A 896 SER A 897 0 -2.47 CISPEP 3 GLU A 985 PRO A 986 0 7.42 SITE 1 AC1 9 ALA A 853 VAL A 884 MET A 902 GLU A 903 SITE 2 AC1 9 TYR A 904 LEU A 905 GLY A 908 LEU A 956 SITE 3 AC1 9 HOH A4113 CRYST1 47.540 75.440 87.980 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021035 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011366 0.00000 MASTER 283 0 1 13 12 0 3 6 0 0 0 23 END